Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

C3_RECTUM_ADENO_MUCINO

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Cause of death: ICD-10 — C20.92& Cancer registry: Topography ICD-O-3 — C19\|C20 Cancer registry: Morphology ICD-O-3 — 8140\|8480 Cancer registry: Behaviour codes — 3 2 out of 7 registries used, show all original rules.	4083
4. Check minimum number of events None	4083
5. Include endpoints None	4083
6. Filter based on genotype QC (FinnGen only)	3956

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF9
Name in latin: Carcinoma in situ cavitatis oris, oesophagi sive ventriculi

NAME	C3_RECTUM_ADENO_MUCINO
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C2092
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C19\|C20
CANC_TOPO_EXCL
CANC_MORPH	8140\|8480
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3956	1461	2495
Unadjusted period prevalence (%)	0.91	0.52	1.14
Median age at first event (years)	67.90	66.44	68.75

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4083: Matched controls
40818

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

WF049

NOMESCO Finland

Radiotherapy of metastasis

1104.5

317.8

307

B01AB10

ATC

tinzaparin; parenteral

5.8

307.7

711

1436

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1245.8

307.7

720

WX408

NOMESCO Finland

General anesthesy, balanced

4.6

307.7

1709

5526

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

307.7

323

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

16384.0

307.7

1975

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

148.6

307.7

303

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

110.6

307.7

288

A04AA02

ATC

granisetron; systemic, transdermal

1317.4

307.7

1070

JN4CD

NOMESCO Finland

Very extensive body CT

18.7

307.7

394

232

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

307.7

497

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

20.4

307.7

1171

789

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

307.7

979

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

307.7

708

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

7114.8

307.7

618

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2585.6

307.7

481

L01BC06

ATC

capecitabine; oral

+∞

307.7

1927

JN4BD

NOMESCO Finland

Extensive body CT

20.8

307.7

1360

959

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

1594.6

307.7

425

JFF10

NOMESCO Finland

Loop enterostomy

104.4

307.7

227

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

415.2

307.7

477

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

21.2

307.7

633

351

WX402

NOMESCO Finland

General anaesthesia

4.6

307.7

1266

3632

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

6679.6

307.7

586

SPAT1125

SPAT

Stoma care and guidance

16.5

307.7

319

209

JG1BG

NOMESCO Finland

MRI of rectum

623.9

307.7

633

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

457.3

307.7

484

TJF80

NOMESCO Finland

Ostomy education

196.4

307.7

589

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

307.7

3481

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

553.9

307.7

488

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

219.0

307.7

208

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

10.3

307.7

451

488

WX302

NOMESCO Finland

Thoracal epidural anesthesy

60.6

307.7

1402

349

TPX10

NOMESCO Finland

Implantation of vascular injection port

12.4

307.7

342

298

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

307.7

473

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

1944.6

307.7

341

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

307.7

462

UJF32

NOMESCO Finland

Coloscopy

11.6

307.7

2877

6970

Z51.5

ICD-10 Finland

Palliative care

11.0

307.7

684

733

Z93.3

ICD-10 Finland

Colostomy status

142.4

307.7

544

A04AA01

ATC

ondansetron; systemic, rectal

17.3

307.7

558

371

C20

ICD-10 Finland

Malignant neoplasm of rectum

7729.9

307.7

1150

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

307.7

553

XX3DW

NOMESCO Finland

Time consuming IT work

14.4

307.7

959

850

JN4AD

NOMESCO Finland

Body CT examination

12.3

307.7

1048

1117

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

85.3

307.7

509

TPH07

NOMESCO Finland

Cathetrisation of artery

5.5

307.7

1044

2385

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

6841.9

307.7

598

WZC00

NOMESCO Finland

Treatment plan or consultation

4.8

307.7

2005

6889

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

307.7

496

ZXC96

NOMESCO Finland

Robot assisted procedure

42.3

307.7

273

WZC30

NOMESCO Finland

Teaching

5.9

307.7

1184

2631

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

307.7

506

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

2305

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

94.6

307.7

181

N02AA05

ATC

oxycodone; systemic

4.3

307.7

1178

3493

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

197.0

307.7

376

H02AB02

ATC

dexamethasone; systemic

101.2

307.7

1264

180

JFF23

NOMESCO Finland

Transversostomy

270.4

307.7

906

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

29.8

307.7

722

292

WF002

NOMESCO Finland

Radical radiotherapy

140.2

307.7

370

WX600

NOMESCO Finland

Single shot through catheter

73.2

307.7

385

A03FA01

ATC

metoclopramide; systemic, rectal

18.6

307.7

2152

2305

C61

ICD-10 Finland

Malignant neoplasm of prostate

514.4

307.7

376

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

24.9

307.7

1960

1458

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

307.7

3426

D75

ICPC

Malignant neoplasm colon/rectum

685.2

307.7

538

B01AB05

ATC

enoxaparin; parenteral

6.1

307.7

2422

7834

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

307.7

317

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

350.2

307.7

493

UJG02

NOMESCO Finland

Proctoscopy

20.3

307.7

526

295

JG1CG

NOMESCO Finland

Extensive MRI of rectum

488.6

307.7

513

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

269.3

307.7

819

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

3022.7

305.8

292

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

13.4

299.9

290

232

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

38.6

294.0

181

ZXE20

NOMESCO Finland

More than three and less than five hours

4.1

289.7

984

2940

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

1497.3

287.7

277

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

2760.4

281.3

269

ZX070

NOMESCO Finland

Intensity modified radiotherapy

965.5

279.4

271

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

138.5

267.0

134

ZX090

NOMESCO Finland

Other technic of radiotherapy

318.0

264.5

266

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

904.6

262.4

255

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

6.5

260.9

453

764

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

257.0

244

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

5.6

255.2

528

1053

L03AA02

ATC

filgrastim; parenteral

69.8

248.2

135

L02AE02

ATC

leuprorelin; implant, parenteral

57.5

247.2

139

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

15.2

243.6

217

150

JN3AD

NOMESCO Finland

Abdominal CT examination

4.1

240.5

773

2198

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

1228.1

239.9

232

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

817.8

238.0

232

A04AA55

ATC

palonosetron, combinations; systemic

+∞

229.3

218

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

10.6

227.5

256

257

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

340.1

222.1

223

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

220.8

210

116

Kela drug reimbursment

Prostate cancer

+∞

214.5

204

WF004

NOMESCO Finland

Palliative radiotherapy

2057.9

214.3

206

ZX120

NOMESCO Finland

Intravenous

4.5

211.5

581

1462

JF2AB

NOMESCO Finland

Colongraphy with X-ray

68.3

207.0

113

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.0

204.6

477

1050

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

54.2

204.0

116

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

37.1

202.8

126

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.0

200.7

649

1840

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

196.4

187

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

38.6

195.2

120

WF003

NOMESCO Finland

Adjuvant radiotherapy

503.8

195.2

193

L01BC59

ATC

trifluridine, combinations; systemic

+∞

193.3

184

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

18.4

191.3

154

WX306

NOMESCO Finland

Lumbar epidural anesthesy

6.1

188.9

348

618

WW500

NOMESCO Finland

Blood transfusion

8.1

188.0

259

337

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

4.3

184.3

520

1330

JAH00

NOMESCO Finland

Laparotomy

7.6

182.7

267

372

D18

ICPC

Change in faeces/bowel movements

7.7

182.3

262

358

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

5.3

179.9

384

781

JFB00

NOMESCO Finland

Partial resection of small intestine

11.2

172.1

184

171

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.6

170.2

653

2068

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

25.5

170.1

119

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

12.4

166.1

166

139

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

165.7

158

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

164.7

157

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

6.7

163.8

270

428

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

6.3

163.6

288

488

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

69.9

163.5

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

48.6

163.3

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

161.5

154

D99

ICPC

Disease digestive system other

13.0

158.6

154

123

A04AD12

ATC

aprepitant; systemic

1620.1

157.3

152

TQW40

NOMESCO Finland

Remowal of suture of skin

4.1

156.5

463

1222

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

15.4

155.0

136

Z93

ICD-10 Finland

Artificial opening status

206.7

154.0

159

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

9.5

153.9

186

205

ZXE30

NOMESCO Finland

More than five and less than seven hours

5.0

151.0

348

754

JGB37

NOMESCO Finland

Laparoscopic wide excision of rectum

+∞

145.7

139

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

52.9

145.2

R4110

NOMESCO Finland

Physiotherapy

2.4

141.5

1350

6902

8480/3-C20.9

ICD-O-3

Mucinous adenocarcinoma of rectum, NOS

+∞

140.4

134

K56.7

ICD-10 Finland

Ileus, unspecified

7.9

137.9

193

255

SPAT1262

SPAT

Handing over of treatment supplies

2.6

137.8

1079

5027

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

137.8

1115

5276

369

Kela drug reimbursment

Regorafenib

+∞

135.1

129

115

Kela drug reimbursment

Breast cancer

+∞

135.1

129

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

18.0

134.7

109

ZZR00

NOMESCO Finland

Flap of skin

15.3

134.3

118

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

133.0

127

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

19.0

131.9

104

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

1309.2

131.0

127

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

658.6

130.2

128

Z51.0

ICD-10 Finland

Radiotherapy session

1277.2

127.8

124

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

127.8

122

L02BG04

ATC

letrozole; oral

28.9

127.0

A79

ICPC

Malignancy NOS

152.7

126.0

133

JGB36

NOMESCO Finland

Wide excision of rectum

1256.0

125.7

122

PJA12

NOMESCO Finland

Sentinel node biopsy

427.1

125.5

125

Z43.3

ICD-10 Finland

Attention to colostomy

169.1

125.1

131

B01AB04

ATC

dalteparin; parenteral

4.3

122.5

339

847

L03AA13

ATC

pegfilgrastim; parenteral

412.8

121.3

121

176

Kela drug reimbursment

Regorafenib

+∞

120.4

115

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

34.2

116.5

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

7.4

113.2

166

231

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

113.0

108

Z93.2

ICD-10 Finland

Ileostomy status

23.6

112.5

JN2BD

NOMESCO Finland

Extensive CT exmaniation of lower part of abdomen

47.1

110.9

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

22.4

107.5

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

106.7

102

A06AH03

ATC

naloxegol; oral

15.7

106.1

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.9

106.0

196

347

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

105.7

101

JGB01

NOMESCO Finland

Laparoscopic partial proctectomy and colorectal or coloanal anastomosis

352.6

103.6

104

R4190

NOMESCO Finland

Nutritional therapy

6.1

102.3

181

307

ZXE10

NOMESCO Finland

More than one and less than three hours

2.1

100.5

1560

9435

JFF26

NOMESCO Finland

Sigmoidostomy

49.0

99.7

JJB10

NOMESCO Finland

Atypcal resection of liver

+∞

98.3

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

4.2

96.2

265

658

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.7

95.3

320

915

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

20.9

95.3

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

95.2

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

14.5

93.0

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.2

92.0

195

391

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

17.2

92.0

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

91.0

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

21.3

89.3

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

876.8

88.0

1541A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,INVASIIVINEN KARSINOOMA]

+∞

87.8

JAH01

NOMESCO Finland

Laparoscopy

4.9

87.6

201

431

HAB40

NOMESCO Finland

Wedge excision of mammary gland

16.0

86.4

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

5.7

86.3

163

294

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

5.8

85.6

160

286

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

85.0

590

2543

JG1DG

NOMESCO Finland

Very extensive MRI of rectum

426.2

84.3

Z43.2

ICD-10 Finland

Attention to ileostomy

131.4

84.3

N03AX16

ATC

[U] pregabalin

2.1

83.3

1059

5879

N02BE01

ATC

paracetamol; systemic, rectal

2.6

83.1

3624

30709

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

15.6

82.9

1XC07, ,

NOMESCO Finland

+∞

82.6

D70.82

ICD-10 Finland

Drug-induced neutropenia

17.3

82.5

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.0

82.2

240

621

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

6.0

82.1

147

252

Y77

ICPC

Malignant neoplasm prostate

211.7

80.6

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

4.0

79.8

235

612

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

793.4

79.7

JFF27

NOMESCO Finland

Laparoscopic sigmoidostomy

209.1

79.5

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

7.5

79.2

115

158

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

783.0

78.6

WX704

NOMESCO Finland

Intubation

2.9

78.0

390

1419

Z31.5

ICD-10 Finland

Genetic counselling

4.9

77.8

176

373

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

76.3

JGB20

NOMESCO Finland

Partial rectosigmoidectomy and abdominoperineal pull-through anastomosis

+∞

76.3

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

76.3

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

17.5

75.7

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

7.4

75.0

109

150

NK6AN

NOMESCO Finland

Total body bone isotope imaging

21.0

74.3

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

13.2

73.4

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

7.3

73.2

108

151

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

73.1

E0000UV, ,

ATC

1.8

72.7

1637

10912

XJG12

NOMESCO Finland

Transrectal endoscopic ultrasonography

33.2

71.7

JG1CM

NOMESCO Finland

Extensive MRI of rectum (more than 1.5 T)

358.3

70.8

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

700.0

70.3

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

12.8

70.0

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

18.3

69.9

JFB30

NOMESCO Finland

Right hemicolectomy

10.9

69.7

XX1AD

NOMESCO Finland

Other CT-examination

148.6

69.1

JFF24

NOMESCO Finland

Laparoscopic transversostomy

347.9

68.8

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

4.0

68.8

205

538

TPX15

NOMESCO Finland

Removal of vascular injection port

25.5

68.7

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

11.3

68.4

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

18.0

68.0

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

26.4

68.0

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

13.6

67.3

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

230.4

66.4

D16

ICPC

Rectal bleeding

4.6

65.9

159

355

L02BB03

ATC

bicalutamide; oral

+∞

65.8

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

15.6

65.7

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

18.8

65.7

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

648.2

65.1

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

27.8

64.8

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.4

63.7

240

737

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.1

63.3

177

443

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

63.1

699

3642

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.9

62.7

146

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

+∞

61.6

K92.1

ICD-10 Finland

Melaena

2.8

61.2

329

1240

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

5.0

60.9

134

277

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

596.6

59.9

L01XE21

ATC

[U] regorafenib

+∞

59.5

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

21.2

58.5

C21.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal

+∞

58.5

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

21.7

57.8

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

57.4

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

57.4

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

565.7

56.7

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

3.9

56.7

171

452

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

56.4

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

56.4

1120

7071

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

196.0

56.1

D28

ICPC

Limited function/disability (D)

16.4

55.6

KCC10

NOMESCO Finland

Cystoprostatectomy

+∞

55.3

L01BC53

ATC

tegafur, combinations; systemic

+∞

55.3

D17

ICPC

Incontinence of bowel

6.7

55.2

134

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

6.8

55.1

131

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

54.3

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

54.3

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

144.4

54.0

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

7.3

53.8

110

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

53.2

Z3231

NOMESCO Finland

Registered nurse

1.8

53.0

1096

6979

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.5

52.7

364

1551

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

524.5

52.6

HAC20

NOMESCO Finland

Total mastectomy

113.5

51.9

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.7

51.8

307

1215

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.8

51.4

161

437

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

4.9

50.8

112

232

G04BE03

ATC

sildenafil; oral

9.5

50.7

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.4

50.6

130

305

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

50.5

817

4821

K43.5

ICD-10 Finland

Parastomal hernia without obstruction or gangrene

134.2

49.9

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

3.6

49.7

165

466

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

49.2

1470

10312

JAG41

NOMESCO Finland

Repair of stomal hernia, laparoscopic

253.1

49.1

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

48.8

1895

14186

R50.9

ICD-10 Finland

Fever, unspecified

2.0

48.6

575

3049

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

483.4

48.4

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

247.8

48.1

KCD02

NOMESCO Finland

Transurethral resection of bladder

9.1

48.1

L01EX05

ATC

regorafenib; oral

+∞

48.0

S18

ICPC

Laceration/cut

1.6

47.8

1797

13326

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

6.4

47.3

123

JGB11

NOMESCO Finland

Laparoscopic partial proctectomy and end colostomy

+∞

47.0

UJF34

NOMESCO Finland

Left colonoscopy

8.9

46.6

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.2

46.6

191

JEA00

NOMESCO Finland

Appendectomy

2.8

46.2

240

886

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

161.8

45.9

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

44.9

HA1AA

NOMESCO Finland

X-ray mammography

3.9

44.8

134

352

JHA00

NOMESCO Finland

Anal or perianal incision

5.7

44.6

151

ZZR10

NOMESCO Finland

Flap of skin and muscle

16.0

44.3

V03AF03

ATC

calcium folinate; systemic

442.3

44.3

L02BA01

ATC

tamoxifen; oral

64.5

44.2

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

11.3

44.0

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.6

43.9

274

1110

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

82.7

43.9

JJB71

NOMESCO Finland

Laparoscopic resection of liver

+∞

43.8

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

43.8

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.4

43.7

111

258

Z85.0

ICD-10 Finland

Personal history of malignant neoplasm of digestive organs

17.3

43.7

UJF30

NOMESCO Finland

Ileoscopy through colon

2.1

43.1

431

2142

6434

FHL

Anterior resection

81.0

42.9

D77

ICPC

Malignant digestive neopl other/NOS

116.3

42.8

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

7.0

42.8

D29

ICPC

Digestive symptom/complaint other

4.0

42.6

123

315

WGA11

NOMESCO Finland

Planning of pain management

12.1

41.9

JJB30

NOMESCO Finland

Excision of two segments of liver

148.2

41.8

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

41.7

ZXD05

NOMESCO Finland

Urgent procedure

1.6

41.6

1189

8171

C50.99

ICD-10 Finland

Breast, unspecified

411.6

41.2

OAB50, ,

SPAT

2.4

41.1

286

1219

WX725

NOMESCO Finland

Noninvasive ventilation

2.7

40.9

237

926

6435

FHL

Abdominoperineal resection and colostomy

144.8

40.8

J01MA12

ATC

levofloxacin; systemic

1.8

40.6

754

4607

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.7

40.3

225

862

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

401.3

40.2

T81.9

ICD-10 Finland

Unspecified complication of procedure

4.4

40.0

102

238

JG001

NOMESCO Finland

Preopertaive radiotherapy of rectum

+∞

39.6

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

39.6

319

1451

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

39.2

2459

20149

JFB54

NOMESCO Finland

Laparoscopic resection of sigmoid colon with partial proctectomy

64.9

39.1

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.9

39.1

178

A02BC02

ATC

pantoprazole; systemic

1.6

39.1

2598

21558

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

38.6

D01.2

ICD-10 Finland

Carcinoma in situ: Rectum

+∞

38.6

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

38.6

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

51.6

38.6

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

13.4

38.2

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

196.8

37.8

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

84.9

37.8

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

37.5

354

1716

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

37.5

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

37.5

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

37.5

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

4.9

37.4

169

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.7

37.3

120

332

JFA70

NOMESCO Finland

Suture of small intestine

13.1

36.5

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

+∞

36.5

ZXE00

NOMESCO Finland

One hour or less

1.6

36.1

1375

10041

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

360.4

36.0

JFB43

NOMESCO Finland

Left hemicolectomy

9.8

35.6

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

+∞

35.5

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

11.3

35.3

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

350.1

35.0

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

8.7

34.9

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

6.1

34.8

LEC00

NOMESCO Finland

Partial excision of vagina

124.4

34.7

K61.1

ICD-10 Finland

Rectal abscess

11.3

34.4

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

51.7

34.4

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

34.4

SPAT1153

SPAT

Removal of sutures

1.6

34.2

1216

8722

P01AB01

ATC

metronidazole; oral, rectal

1.5

34.2

1368

10073

JFB20

NOMESCO Finland

Ileocaecal resection

9.8

33.9

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

33.4

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

5.0

33.1

144

JKA20

NOMESCO Finland

Cholecystectomy

3.0

33.0

146

493

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.5

33.0

212

870

UKC02

NOMESCO Finland

Cystoscopy

1.7

32.9

680

4259

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

35.3

32.8

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.9

32.6

254

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

+∞

32.3

C209, ,

ICD-10 Finland

+∞

32.3

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

3.5

32.3

112

326

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

32.2

309

1506

SPAT1109

SPAT

Analgesia with portable analgesic pump

10.7

32.2

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

32.2

311

1520

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

5.2

31.9

126

A06AD11

ATC

lactulose; oral

1.7

31.3

658

4136

JJB20

NOMESCO Finland

Excision of single segment of liver

+∞

31.3

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

31.3

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

31.3

J01MA02

ATC

ciprofloxacin; systemic

1.5

31.2

1514

11551

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

315.2

30.9

KA3EB

NOMESCO Finland

Antegrade pyelography

10.4

30.7

Z71.8

ICD-10 Finland

Other specified counselling

1.6

30.4

1018

7170

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

30.3

460

2630

JN2AD

NOMESCO Finland

CT examination of lower part of abdomen

11.6

30.0

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

29.9

631

3966

L03AA14

ATC

lipegfilgrastim; parenteral

304.5

29.8

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

3.9

29.8

225

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

83.2

29.8

Y83.2

ICD-10 Finland

Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

8.7

29.3

8480/3-C19.9

ICD-O-3

Mucinous adenocarcinoma of rectosigmoid junction

+∞

29.2

L02BX02

ATC

degarelix; parenteral

+∞

29.2

JG1BM

NOMESCO Finland

MRI of rectum (more than 1.5 T)

+∞

29.2

C50

ICD-10 Finland

Malignant neoplasm of breast

293.9

28.8

JFB46

NOMESCO Finland

Resection of sigmoid colon

5.1

28.7

119

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

151.0

28.7

ZX050

NOMESCO Finland

Stereotactic radiotherapy

44.1

28.7

WX882

NOMESCO Finland

High dependency care

3.0

28.4

131

453

LCD00

NOMESCO Finland

Hysterectomy

2.8

28.4

142

514

ZX112

NOMESCO Finland

Subcutaneous

5.6

28.3

JAD10

NOMESCO Finland

Repair of incisional hernia

5.6

28.3

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

28.1

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

28.1

15411

ICD-8 Finland

Malignant neoplasm of rectum and rectosigmoid junction, Rectum

+∞

28.1

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

5.0

27.9

122

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

27.8

161

628

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

283.3

27.8

KC1GB

NOMESCO Finland

Cystography with X-ray

28.7

27.6

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

27.5

577

3616

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.0

27.1

191

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

27.1

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

27.1

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

27.1

TJG20

NOMESCO Finland

Transanal irrigation

26.6

27.0

N02AX02

ATC

tramadol; systemic, rectal

1.4

26.9

1598

12576

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

32.1

26.8

KBV00

NOMESCO Finland

Insertion of stent into ureter

7.1

26.7

K43.3

ICD-10 Finland

Parastomal hernia with obstruction, without gangrene

97.4

26.7

ZX121

NOMESCO Finland

Central venous catheter

27.9

26.6

R19.4

ICD-10 Finland

Change in bowel habit

2.9

26.3

128

457

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

5.5

26.0

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

40.3

25.8

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

262.2

25.7

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

135.8

25.6

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

5.5

25.5

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

25.2

JFG30

NOMESCO Finland

Closure of colostomy with resection of exteriorised loop

35.8

25.2

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

25.0

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

24.7

548

3478

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.3

24.6

152

XX2RW, ,

NOMESCO Finland

6.8

24.6

WX892

NOMESCO Finland

Monitored bed care

1.9

24.6

318

1723

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

24.5

290

1524

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

5.1

24.4

101

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

9.4

24.4

JAG43

NOMESCO Finland

Repair of stomal hernia with mesh

56.3

24.0

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

56.3

24.0

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

24.0

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

24.0

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

24.0

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

24.0

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

8.1

23.9

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.2

23.8

203

943

NET99

NOMESCO Finland

Other operation on pelvis

241.3

23.7

R33

ICD-10 Finland

Retention of urine

1.8

23.4

394

2317

UJF32, ,

SPAT

2.8

23.3

121

447

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

4.0

23.3

163

K56.0

ICD-10 Finland

Paralytic ileus

4.0

23.1

164

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

3.9

23.1

173

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

54.3

23.0

JFF30

NOMESCO Finland

Other colostomy

24.8

23.0

ZXC40

NOMESCO Finland

Use of ultrasound

8.0

23.0

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

22.9

1XC08, ,

NOMESCO Finland

+∞

22.9

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

22.9

1541X

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,EI HISTOLOGISTA VAHVISTUSTA]

+∞

22.9

JJB40

NOMESCO Finland

Excision of segments II, III and IV of liver

+∞

22.9

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.6

22.8

216

N82.3

ICD-10 Finland

Fistula of vagina to large intestine

30.2

22.7

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

22.7

1158

8795

L02AE04

ATC

triptorelin; parenteral

231.2

22.6

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

7.8

22.5

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.2

22.3

284

JAG00

NOMESCO Finland

Repair of other hernia

24.0

22.1

XJW99

NOMESCO Finland

Other investigative procedure on digestive system

9.1

22.1

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

21.9

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

21.9

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

21.9

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

4.5

21.7

120

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

80.5

21.7

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

115.6

21.6

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.7

21.5

664

9349

G04CA02

ATC

tamsulosin; oral

1.4

21.5

1212

9356

JFA42

NOMESCO Finland

Endoscopic injection in colon

6.8

21.2

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

20.8

21.2

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

7.3

21.2

XKD00

NOMESCO Finland

Uroflowmetry

1.5

21.0

647

4432

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

20.8

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

20.8

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

20.8

A28

ICPC

Limited function/disability NOS

1.5

20.8

733

5166

ZYC01

NOMESCO Finland

Remote contact by phone

2.1

20.8

197

955

R03AC02

ATC

salbutamol; inhalant

0.7

20.7

1253

15615

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

20.6

551

3653

128

Kela drug reimbursment

Cancers of female genital organs

211.0

20.6

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.4

20.5

146

629

R11

ICD-10 Finland

Nausea and vomiting

1.9

20.4

284

1575

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.7

20.4

689

9543

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

57.8

19.9

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

3.9

19.9

146

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

19.8

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

19.8

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

19.8

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

19.8

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

19.8

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

19.8

X76

ICPC

Malignant neoplasm breast female

73.8

19.7

WX610

NOMESCO Finland

Patient controlled analgesia

6.6

19.6

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.4

19.5

209

S77

ICPC

Malignant neoplasm of skin

19.5

WX002

NOMESCO Finland

Sedation and analgesia

1.5

19.3

703

4979

JGA98

NOMESCO Finland

Other transluminal endoscopic local operation on rectum

46.2

19.2

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

6.5

19.2

JN6AD

NOMESCO Finland

CT of torso and neck

5.4

19.0

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

55.3

18.9

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

55.3

18.9

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.7

18.8

615

8601

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

18.8

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

18.8

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

18.8

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

18.8

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

18.8

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

+∞

18.8

JAL30

NOMESCO Finland

Omentectomy

7.7

18.7

M25.5

ICD-10 Finland

Pain in joint

0.7

18.7

557

7936

GDC00

NOMESCO Finland

Lobectomy of lung

20.9

18.6

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

18.4

396

2485

K46.9

ICD-10 Finland

Unspecified abdominal hernia without obstruction or gangrene

5.2

18.4

WVA20

NOMESCO Finland

Medicine administration

2.8

18.4

345

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

44.2

18.2

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

44.2

18.2

GDB10

NOMESCO Finland

Wedge resection of lung

25.1

18.2

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.2

18.2

151

695

KBH20

NOMESCO Finland

Replantation of ureter

19.4

18.2

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.7

17.9

524

7507

UJH02

NOMESCO Finland

Anoscopy

2.2

17.9

154

719

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

16.6

17.8

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

17.8

144

656

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

18.1

17.7

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

17.7

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

17.7

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

17.7

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

17.7

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

17.7

A07DA03

ATC

loperamide; oral

2.3

17.6

140

633

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

95.5

17.6

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

180.7

17.5

LEE10

NOMESCO Finland

Repair of vagina using graft or flap

180.7

17.5

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

17.1

407

2619

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

31.6

17.0

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

13.3

16.9

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

4.8

16.8

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.4

16.8

Z3226

NOMESCO Finland

Physiotherapist

1.5

16.7

608

4298

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

16.7

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

16.7

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

16.7

K62.7

ICD-10 Finland

Radiation proctitis

+∞

16.7

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

16.7

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

16.7

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

16.6

227

1251

JFK00

NOMESCO Finland

Division of adhesive band in intestinal obstruction

12.7

16.6

C10AX09

ATC

ezetimibe; oral

0.6

16.6

315

4982

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

170.6

16.5

JFF13

NOMESCO Finland

Terminal enterostomy

18.0

16.4

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.0

16.4

168

840

N32.1

ICD-10 Finland

Vesicointestinal fistula

6.8

16.1

KA1FN

NOMESCO Finland

Isotope renography

6.0

16.0

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

16.0

277

1639

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

24.5

16.0

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

21.0

16.0

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

15.9

140

660

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.0

15.9

167

842

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

15.7

518

7270

R19.5

ICD-10 Finland

Other faecal abnormalities

3.0

15.7

234

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

15.6

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

15.6

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

15.6

KH1BD

NOMESCO Finland

Extensive urinary tract CT examination

4.6

15.6

TJX90

NOMESCO Finland

Other minor procedure in gastroenterological surgery

17.2

15.6

Z93.8

ICD-10 Finland

Other artificial opening status

160.6

15.5

JFB50

NOMESCO Finland

Other resection of colon

13.8

15.5

UKB02

NOMESCO Finland

Retrograde ureteroscopy

3.8

15.4

126

C209, 8148, 2

ICD-O-3

38.2

15.4

R18

ICD-10 Finland

Ascites

3.0

15.3

226

XJH00

NOMESCO Finland

Transanal ultrasonography

1.8

15.2

243

1405

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.7

15.2

132

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

17.8

15.1

K62.1

ICD-10 Finland

Rectal polyp

3.4

15.0

162

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

6.3

15.0

K45.0

ICD-10 Finland

Other specified abdominal hernia with obstruction, without gangrene

14.0

15.0

K83.1

ICD-10 Finland

Obstruction of bile duct

4.0

14.9

102

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

6.5

14.9

L02BG03

ATC

anastrozole; oral

56.9

14.8

G47.3

ICD-10 Finland

Sleep apnoea

0.7

14.7

445

6366

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.1

14.7

JJA43

NOMESCO Finland

Destruction of lesion of liver

+∞

14.6

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

14.6

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

14.6

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

+∞

14.6

L02BB04

ATC

enzalutamide; oral

+∞

14.6

L01BC04

ATC

carmofur; oral

+∞

14.6

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

14.6

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

+∞

14.6

WB600

NOMESCO Finland

Neoadjuvant therapy of primary tumour with antibodies

+∞

14.6

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

150.5

14.5

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

150.5

14.5

R01AD09

ATC

mometasone; nasal

0.7

14.5

897

11320

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

27.2

14.3

R15

ICD-10 Finland

Faecal incontinence

2.3

14.2

109

486

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.2

14.2

168

WPB10

NOMESCO Finland

Making a convalescent care decision

14.4

14.0

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

30.1

13.9

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

30.1

13.9

N13.0

ICD-10 Finland

Hydronephrosis with ureteropelvic junction obstruction

5.6

13.8

JFB40

NOMESCO Finland

Resection of transverse colon

53.5

13.8

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

3.4

13.8

146

HAB99

NOMESCO Finland

Other partial excision of mammary gland

4.9

13.8

JGA96

NOMESCO Finland

Other proctotomy or local operation on rectum

23.8

13.8

JGA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in rectum

13.6

13.7

D07AA02

ATC

hydrocortisone; topical

1.5

13.7

413

2803

N02AA01

ATC

morphine; systemic, rectal

3.1

13.6

188

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

3.7

13.6

114

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

13.5

JF2CG

NOMESCO Finland

Extensive MRI of colon

+∞

13.5

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

13.5

JFC10

NOMESCO Finland

Ileotransversostomy

+∞

13.5

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

13.5

Z93.4

ICD-10 Finland

Other artificial openings of gastrointestinal tract status

34.1

13.5

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

140.4

13.4

OAA41

NOMESCO Finland

Health check based on individual needs

140.4

13.4

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

0.7

13.4

569

7654

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.5

13.4

319

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

21.2

13.3

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.2

13.2

112

522

G04BE01

ATC

alprostadil; parenteral, urethral

2.6

13.1

281

K65.0

ICD-10 Finland

Acute peritonitis

3.2

13.1

166

SPAT1131

SPAT

Colonoscopy

2.1

13.1

125

609

K60.4

ICD-10 Finland

Rectal fistula

12.2

13.1

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

13.0

140

713

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(4035726) Immunohistochemistry procedure

910

791

14.51

307.65

1.3

1.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3064

15263

5.03

307.65

14.6

3.8

11.01

12.27

umol/l

6.60

3004

14256

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

947

594

20.45

307.65

5.9

1.8

578.19

23.54

u/ml

0.80

867

467

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3231

1643

90.42

307.65

9.8

1.4

33.88

2.72

ug/l

2.94

2948

1221

(3002256) Pathology report gross observation

912

2205

5.04

307.65

1.3

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

480

347

15.54

307.65

5.1

1.9

55.51

21.92

u/ml

3.50

432

312

(40768804) Tissue Pathology biopsy report

2117

9390

3.60

307.65

2.7

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1836

6781

4.10

307.65

3.3

2.2

—

(3022145) Colonoscopy Study observation

1851

3082

10.15

307.65

1.6

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1230

3105

5.24

307.65

2.6

2.2

7.15

8.01

umol/l

0.68

1140

2674

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1018

2565

4.95

307.65

2.1

2.2

31.51

56.10

u/l

0.71

937

2151

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2875

13352

4.90

307.65

3.8

2.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2818

13310

4.60

307.65

10.7

3.9

33.25

35.38

g/l

67.30

2748

12130

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1215

2320

7.03

307.65

2.3

2.0

0.21

0.20

g/l

3.96

1184

2088

(3044640) Blood type and Crossmatch panel - Blood

2181

8841

4.15

307.65

3.5

2.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

2858

16274

3.52

300.57

12.3

19.3

1.20

1.38

inr

21.79

799

4504

(3033658) Prothrombin time (PT) actual/Normal

1718

7355

3.31

290.66

5.0

3.6

89.69

84.71

14.07

1710

7150

(3013650) Neutrophils [#/volume] in Blood by Automated count

2735

16557

2.97

230.99

16.8

6.1

3.89

4.39

e9/l

25.00

2433

14159

(3023368) Bacteria identified in Blood by Culture

1803

8932

2.82

221.19

5.1

3.9

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1908

9914

2.73

210.62

2.6

2.3

57.36

60.38

u/l

1.45

1837

9053

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3363

23873

3.32

193.94

16.0

5.4

88.81

75.89

u/l

27.17

3283

22025

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

603

1716

3.95

184.75

8.7

10.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1762

9293

2.58

181.83

4.3

2.6

31.32

35.58

u/l

1.32

1719

8710

(3003694) ABO and Rh group [Type] in Blood

1486

7247

2.65

180.05

1.4

1.3

—

(3037121) Protein [Mass/volume] in Urine

430

1048

4.47

161.58

6.3

2.6

0.20

0.34

g/l

4.79

332

374

(3015377) Calcium [Moles/volume] in Serum or Plasma

1760

9914

2.36

149.64

8.0

2.1

2.34

2.35

mmol/l

0.96

1635

8268

(3002173) Hemoglobin [Mass/volume] in Arterial blood

819

3192

2.96

149.59

8.2

7.9

117.22

122.58

g/l

13.06

797

3104

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1188

5751

2.50

140.18

9.3

2.2

2.48

2.45

mmol/l

18.37

1118

4903

(3016502) Oxygen saturation in Arterial blood

860

3556

2.80

139.85

8.0

7.3

97.15

95.00

21.80

830

3413

(3013826) Glucose [Moles/volume] in Serum or Plasma

2756

19209

2.34

136.07

6.1

4.5

7.00

6.90

mmol/l

1.84

2674

17949

(3014111) Lactate [Moles/volume] in Serum or Plasma

744

2893

2.92

135.40

6.4

6.6

1.22

1.42

mmol/l

5.57

727

2809

(3003396) Base excess in Arterial blood by calculation

904

3914

2.68

133.77

7.9

7.1

0.76

1.25

mmol/l

3.53

781

3064

(3027801) Oxygen [Partial pressure] in Arterial blood

906

3940

2.67

132.79

7.9

7.0

14.85

11.50

kpa

48.66

873

3739

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

906

3941

2.67

132.71

7.9

7.0

5.21

5.05

kpa

6.94

874

3749

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2220

14527

2.16

122.88

7.5

5.5

1.19

1.21

mmol/l

23.33

2069

12927

(3012095) Magnesium [Moles/volume] in Serum or Plasma

997

4728

2.47

120.58

5.7

2.5

0.79

0.82

mmol/l

19.11

960

4333

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

385

1084

3.82

117.86

2.6

3.1

0.29

0.33

u/ml

1.56

200

644

(3014007) Fractional oxyhemoglobin in Arterial blood

572

2072

3.05

117.17

8.5

9.0

95.51

93.34

18.25

572

2061

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2364

16029

2.13

116.96

8.4

5.9

1.19

1.21

mmol/l

28.57

2026

13547

(3002582) Erythrocytes [#/volume] in Urine

1614

9549

2.14

113.60

3.7

3.1

104.37

69.53

e6/l

0.47

1280

7277

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

480

1663

3.14

105.72

8.7

9.2

24.01

24.35

mmol/l

1.59

473

1591

(3000991) Gas panel - Venous blood

653

2690

2.70

104.55

7.4

8.0

—

(3030467) Casts [#/volume] in Urine by Automated count

1488

8773

2.09

103.44

3.5

3.0

0.55

0.48

e6/l

0.46

1171

6636

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

558

2147

2.85

101.72

1.6

—

(40758558) Short blood count panel - Blood

1257

6991

2.15

101.51

13.5

4.6

—

(36304419) Bacteria [Presence] in Urine

1437

8413

2.09

101.35

3.4

2.9

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2740

20542

2.01

92.18

4.9

4.4

2332.44

2026.38

e6/l

0.06

323

(3018095) Leukocytes [#/volume] in Urine

1700

11040

1.92

85.65

4.3

3.5

168.56

114.18

e6/l

1.35

1319

7833

(3042936) Bacteria identified in Isolate by Culture

841

4411

2.14

75.97

2.2

2.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

912

4963

2.08

74.58

3.4

2.8

2.47

2.08

e6/l

0.49

509

2739

(3026008) Bacteria identified in Urine by Culture

1444

9514

1.80

64.71

3.5

3.2

—

(3000850) Epithelial cells [#/volume] in Urine

1100

6666

1.89

64.60

2.8

2.5

5.31

4.43

e6/l

0.93

1007

5894

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

812

4443

2.03

64.35

2.2

2.7

20.00

22.59

5.43

704

3710

(3026782) Osmolality of Urine

1047

6336

1.88

61.24

3.5

2.8

526.76

548.30

mosm/kgh2o

2.65

940

5339

(3004789) Transferrin [Mass/volume] in Serum or Plasma

838

4747

1.96

59.68

2.2

2.6

2.36

2.28

g/l

3.22

790

4342

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

926

5438

1.91

59.15

3.2

2.6

1.02

1.18

e6/l

0.58

517

3195

(3022948) Iron [Moles/volume] in Serum or Plasma

881

5156

1.90

56.56

2.2

2.6

11.69

12.81

umol/l

3.94

834

4735

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3548

31296

2.02

49.63

29.2

13.9

38.07

24.82

mg/l

77.34

3334

24576

(3037467) Urinalysis macro (dipstick) panel - Urine

2663

21758

1.64

47.30

5.6

4.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

566

3031

2.01

46.38

4.9

7.1

9.56

11.13

mmol/l

4.89

541

2861

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

246

919

2.78

46.35

1.3

1.2

—

(3018418) pH of Serum or Plasma

1322

9227

1.64

43.96

5.1

3.4

7.40

0.19

279

1614

(3006504) Eosinophils/100 leukocytes in Blood

1840

13906

1.59

43.95

4.5

5.6

2.68

2.99

6.54

1711

12763

(3018572) Chloride [Moles/volume] in Blood

211

749

2.92

43.69

8.6

7.2

106.49

104.92

mmol/l

6.08

190

666

(3039000) Anion gap in Blood

211

749

2.92

43.69

8.6

7.2

10.96

11.32

mmol/l

1.04

190

666

(3019069) Monocytes/100 leukocytes in Blood

1845

13982

1.58

43.35

4.7

5.9

9.09

8.87

1.70

1716

12851

(3022096) Basophils/100 leukocytes in Blood

1793

13505

1.58

43.21

4.4

5.6

0.56

0.67

13.57

1662

12387

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

312

1357

2.41

42.95

2.0

1.8

2.43

1.69

ug/l

0.60

282

1169

(3047181) Lactate [Moles/volume] in Blood

266

1077

2.57

42.69

7.6

6.2

1.37

1.33

mmol/l

0.20

235

952

(3002030) Lymphocytes/100 leukocytes in Blood

1869

14275

1.57

41.98

4.6

5.7

22.67

26.68

39.24

1734

13167

(3025941) Bacteria identified in Stool by Culture

332

1500

2.32

41.89

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

863

5438

1.74

41.89

1.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

581

3300

1.89

39.60

4.9

3.3

—

(3048689) Calprotectin [Mass/mass] in Stool

557

3123

1.91

39.50

1.4

2.2

287.62

160.57

ug/g

5.72

441

2459

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1197

8326

1.62

39.47

2.2

2.3

3.33

2.96

mg/l

4.16

1017

7008

(40760892) CBC W Ordered Manual Differential panel - Blood

1816

13929

1.55

39.06

4.8

5.7

—

(3018010) Neutrophils/100 leukocytes in Blood

1835

14125

1.54

38.72

4.4

5.5

61.05

58.20

15.83

1706

13024

(40768800) Prostate Pathology biopsy report

204

4.54

37.55

1.2

1.1

—

(3006315) Basophils [#/volume] in Blood

1907

15074

1.50

33.86

4.3

5.3

0.04

e9/l

13.26

1605

12898

(3001604) Monocytes [#/volume] in Blood

1900

15014

1.50

33.74

4.3

5.3

0.61

0.62

e9/l

0.82

1595

12843

(3008152) Bicarbonate [Moles/volume] in Arterial blood

430

2328

1.95

33.60

8.7

7.2

24.70

24.54

mmol/l

0.42

408

2221

(40768441) Liver Pathology biopsy report

103

5.90

33.47

1.1

1.4

—

(3019060) Gas panel - Arterial blood

441

2432

1.91

32.57

6.5

4.9

—

(3019198) Lymphocytes [#/volume] in Blood

1932

15400

1.48

32.37

4.4

5.4

1.61

1.83

e9/l

2.68

1664

13434

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

309

1513

2.13

31.83

6.8

4.9

1.60

1.63

0.21

283

1414

(3007930) Methemoglobin/Hemoglobin.total in Blood

303

1485

2.12

31.12

6.9

5.0

0.93

0.87

2.19

278

1390

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1572

12096

1.49

31.01

2.6

2.9

161.31

143.83

ug/l

0.67

1438

10976

(3013115) Eosinophils [#/volume] in Blood

1938

15611

1.46

29.85

4.5

5.5

0.18

0.21

e9/l

10.87

1666

13503

(3051651) Icteric interference index of Serum or Plasma

146

4.58

27.74

5.2

4.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

116

386

3.06

26.96

1.2

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3290

29679

1.56

26.62

30.5

12.9

78.16

75.14

ml/min/173m2

15.29

2947

24007

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

365

2021

1.88

26.44

1.7

1.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

631

4118

1.63

25.54

4.4

5.6

1.03

mmol/l

0.16

592

3773

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

157

639

2.51

24.89

1.4

1.3

—

(3021589) Normoblasts [#/volume] in Blood

1662

13321

1.42

24.65

16.3

8.7

0.00

e9/l

0.09

1360

10824

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

159

669

2.43

23.49

2.5

1.4

40.70

22.23

u/ml

1.75

153

633

(3044889) 12 lead EKG panel

2646

23091

1.41

23.37

4.4

4.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3589

33409

1.61

21.35

35.4

17.1

139.23

139.79

mmol/l

34.21

3537

32450

(3023103) Potassium [Moles/volume] in Serum or Plasma

3594

33493

1.61

20.97

35.5

17.2

3.95

4.00

mmol/l

27.51

3541

32483

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

189

908

2.13

20.41

1.9

1.7

—

(40768793) Breast Pathology biopsy report

119

4.33

20.12

1.4

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

735

5237

1.49

19.66

2.0

1.9

30.25

30.08

0.31

719

5061

(40768795) Lymph node Pathology biopsy report

6.50

19.17

1.2

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

544

3684

1.55

18.40

1.8

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

352

2.74

18.27

1.4

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

246

1351

1.87

18.20

2.0

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

361

2.70

17.95

1.4

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

489

3252

1.57

17.90

3.1

2.7

256.66

238.20

u/l

1.20

467

2995

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

356

2.71

17.88

1.4

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

351

2.72

17.82

1.4

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

354

2.69

17.53

1.4

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

367

2.65

17.39

1.4

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

555

3820

1.52

17.37

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2191

19031

1.33

16.99

3.5

3.0

64.03

50.39

u/l

6.24

2056

17279

(40761511) CBC panel - Blood by Automated count

3462

32347

1.46

16.29

28.9

13.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

320

1962

1.68

16.24

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

549

3836

1.50

15.91

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2938

31695

0.74

15.76

4.2

4.9

4.52

4.48

mmol/l

1.23

2655

29073

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2909

31422

0.74

15.67

4.2

4.8

1.43

1.42

mmol/l

0.87

2610

28627

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

224

1253

1.83

15.65

1.9

1.7

—

(3051611) Lipemic interference index of Serum or Plasma

312

2.69

15.58

4.8

3.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

306

4796

0.61

15.41

1.2

14.40

13.73

u/ml

0.05

104

1766

(40762365) Oxygen content in Arterial blood by calculation

5.75

15.37

4.0

2.3

13.56

15.52

ml/dl

2.87

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

155

3.45

15.33

1.2

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

328

5039

0.62

15.16

1.2

1.3

68.35

39.58

iu/ml

1.21

104

1539

(3013707) Erythrocyte sedimentation rate by Westergren method

2627

23606

1.32

15.00

3.3

4.1

16.78

12.60

mm/h

23.92

2403

21611

(40761536) Microorganisms panel - Urine sediment

370

2404

1.59

14.88

4.6

4.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

485

3347

1.51

14.88

2.9

3.6

5.74

5.84

kpa

1.30

469

3242

(3002032) Base excess in Venous blood by calculation

482

3334

1.50

14.61

2.9

3.6

2.00

1.96

mmol/l

0.07

396

2824

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3558

33566

1.46

14.49

19.0

9.4

24.00

25.81

u/l

10.30

3487

31997

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3036

32464

0.75

13.97

4.7

5.5

2.62

2.61

mmol/l

0.22

2715

29653

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

139

690

2.05

13.85

2.4

2.2

217.26

195.28

1.92

133

653

(3013512) EKG study

1251

10287

1.31

13.40

4.2

4.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

382

2568

1.54

13.20

4.6

3.1

1.22

mmol/l

1.31

341

2177

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

415

2.32

13.04

5.4

6.5

11.91

12.05

mg/l

0.08

375

(3012501) Base excess in Blood by calculation

140

716

1.99

12.87

4.3

4.4

2.65

2.64

mmol/l

0.01

102

472

(3018405) Lactate [Moles/volume] in Arterial blood

224

1330

1.72

12.80

4.8

4.2

1.21

1.43

mmol/l

2.49

217

1303

(3019225) pH of Specimen

469

3316

1.47

12.68

4.3

3.7

—

(3010421) pH of Blood

156

847

1.87

12.03

4.1

4.3

7.42

0.81

142

756

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2847

30547

0.77

11.94

6.0

6.5

41.02

40.94

mmol/mol

0.13

2564

28005

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2835

30419

0.78

11.76

3.8

4.3

1.30

mmol/l

0.02

2515

27448

(3014765) Yersinia sp identified in Stool by Organism specific culture

158

869

1.85

11.71

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

2865

26389

1.29

11.71

38.1

16.1

15.63

15.32

2.32

2839

25774

(3023183) Ammonium ion [Moles/volume] in Plasma

131

680

1.96

11.58

2.1

2.5

33.94

34.87

umol/l

0.14

121

601

(3027945) Reticulocytes/100 erythrocytes in Blood

535

3943

1.41

11.51

2.3

2.1

1.75

0.01

478

3427

(42529406) Shigella sp [Presence] in Stool by Culture

158

875

1.84

11.47

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

162

906

1.82

11.39

4.9

3.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

156

863

1.84

11.36

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

282

1835

1.58

11.26

2.3

2.5

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

140

3.17

11.22

2.6

1.6

9.09

4.64

nmol/l

0.40

134

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

206

1242

1.69

11.16

1.0

1.1

—

(3049717) Cytology report of Urine Cyto stain

192

1145

1.71

10.84

2.8

1.8

—

(3004809) Band form neutrophils/100 leukocytes in Blood

389

2.21

10.53

2.5

3.1

3.38

1.46

2.34

329

(3043410) Blood group antigens tested for on Red Blood Cells

4.08

10.40

2.6

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

3620

34617

1.40

10.32

45.3

20.5

38.02

40.39

35.97

3411

31739

(3020891) Body temperature

233

1482

1.61

10.26

5.4

5.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

1754

15403

1.24

10.19

5.5

4.9

0.00

estimate

-0.00

402

2635

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

133

3.10

10.15

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

133

3.10

10.15

1.3

—

(3024731) MCV [Entitic volume]

3620

34646

1.39

10.00

44.9

20.4

91.31

91.58

2.72

3580

33937

(3010813) Leukocytes [#/volume] in Blood

3620

34648

1.39

9.98

45.0

20.4

6.72

6.79

e9/l

0.83

3530

33357

(3035941) MCH [Entitic mass]

3620

34649

1.39

9.97

44.8

20.3

30.14

30.50

23.71

3579

33942

(3026361) Erythrocytes [#/volume] in Blood

3620

34651

1.39

9.95

45.0

20.4

4.26

4.50

e12/l

142.12

3530

33356

(3007461) Platelets [#/volume] in Blood

3619

34640

1.39

9.95

45.1

20.4

248.52

240.17

e9/l

9.65

3539

33502

(3000963) Hemoglobin [Mass/volume] in Blood

3620

34656

1.39

9.89

45.3

20.5

126.84

136.62

g/l

238.48

3578

33952

(3037522) Nuclear Ab [Titer] in Serum

268

3940

0.66

9.89

1.2

1.3

560.00

529.92

titre

0.07

844

(1616796) Gas panel - Central venous blood

132

727

1.84

9.80

3.6

3.9

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

7.81

9.60

1.2

1.1

—

(4281824) Cell count and differential, peritoneal fluid

138

2.99

9.55

1.2

—

(3009261) Glucose [Presence] in Urine by Test strip

1764

15585

1.23

9.43

4.2

3.7

0.00

estimate

1.34

397

2517

(3035350) Ketones [Presence] in Urine by Test strip

1751

15468

1.23

9.35

4.2

3.7

0.00

estimate

1.94

417

2866

(3017181) Myelocytes/100 leukocytes in Blood

341

2405

1.46

9.30

3.2

3.7

1.20

0.80

2.48

150

643

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

185

2.67

9.26

1.2

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

190

2.60

8.81

1.2

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

449

2.00

8.63

1.3

1.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

326

2318

1.44

8.52

3.2

3.8

0.21

0.07

2.48

136

556

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

726

5850

1.29

8.49

1.1

1.2

1.50

2.05

u/ml

0.70

184

1524

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

365

2.10

8.42

1.1

1.65

1.53

g/l

1.27

318

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

8.33

1.1

0.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

364

2653

1.41

8.30

4.5

2.3

62.58

62.32

ml/min/173m2

0.04

148

1019

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

726

8861

0.78

8.23

1.6

1.7

1.46

1.35

mmol/l

1.07

588

7318

(3024354) Oxygen [Partial pressure] in Venous blood

379

2788

1.40

8.18

2.6

3.0

4.65

4.51

kpa

0.53

363

2689

(3036489) Thrombin time

164

1015

1.64

8.12

2.0

1.8

20.96

21.21

0.35

156

890

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

114

3.00

8.02

1.8

2.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

114

642

1.80

7.95

1.3

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

171

2.59

7.91

1.7

1.8

2.54

1.82

u/field

0.37

115

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2143

23290

0.83

7.68

3.1

3.7

15.03

14.98

pmol/l

0.33

1879

20788

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.54

7.68

1.3

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

134

2.78

7.63

1.9

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

308

2214

1.42

7.60

2.9

3.6

0.68

0.61

0.26

129

567

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

501

1.88

7.49

3.8

3.5

59.84

58.85

0.27

501

(3004716) Salmonella sp identified in Stool by Organism specific culture

179

1159

1.57

7.39

1.2

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

396

2987

1.36

7.33

2.3

2.1

67.78

68.07

e9/l

0.05

297

2291

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

117

2.83

7.09

1.4

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

397

1.96

7.09

1.4

1.5

30.74

28.53

g/l

0.73

343

(4200892) Spirometry reversibility

166

2508

0.65

6.98

1.3

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

293

2123

1.41

6.93

3.1

3.5

2.14

1.84

mmol/l

0.66

216

1534

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

834

6988

1.24

6.91

3.3

4.1

571.30

522.04

ng/l

0.11

692

5910

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

303

2219

1.39

6.74

3.1

3.6

5.09

5.16

kpa

0.70

283

2078

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

106

615

1.74

6.74

1.3

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

309

2.05

6.68

1.3

1.4

233.94

68.39

pmol/l

0.83

297

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

961

11154

0.82

6.66

2.1

2.2

205.59

240.72

u/l

0.63

904

10370

(3012441) Differential panel - Pleural fluid

298

2.06

6.55

1.4

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

117

2.75

6.52

1.4

1.3

—

(3009343) pH of Capillary blood

298

2192

1.39

6.46

3.1

3.6

7.42

0.11

265

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.07

6.45

1.4

1.3

—

(3045142) Bone marrow Pathology biopsy report

221

2.23

6.43

1.2

—

(3025159) Blasts/100 leukocytes in Blood

300

2219

1.38

6.30

3.3

3.8

0.54

0.07

0.48

110

468

(3029937) Albumin [Presence] in Urine by Test strip

993

8551

1.21

6.24

4.4

4.1

0.01

0.00

estimate

0.35

351

2544

(3000012) Reticulocyte production index

452

1.83

6.21

2.1

1.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

606

4972

1.26

6.00

1.4

1.3

2.61

2.71

g/l

0.44

329

2836

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1533

13769

1.18

5.98

3.6

4.0

66.81

83.03

ng/l

0.18

1220

10293

(40767503) Oxygen content in Capillary blood by calculation

115

706

1.65

5.98

2.8

2.5

15.17

16.29

1.54

381

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

312

2346

1.36

5.92

1.3

1.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

256

2.08

5.90

1.2

1.3

279.38

272.29

u/l

0.04

240

(1002224) Polysomnography panel

994

0.50

5.89

1.0

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

130

827

1.59

5.86

1.6

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

224

2.16

5.83

1.3

1.4

—

(40768806) Pleura Pathology biopsy report

272

2.04

5.76

1.4

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.92

5.72

1.4

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.92

5.72

1.4

1.3

—

(3045414) Leukocytes [Presence] in Urine

202

1420

1.44

5.69

2.3

1.9

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3027

31579

0.84

5.50

4.5

5.1

6.15

6.10

mmol/l

1.20

2700

28432

(3026493) Urate [Moles/volume] in Serum or Plasma

779

9066

0.83

5.36

2.4

2.5

3115.17

5724.05

umol/l

1.28

665

7761

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

118

1803

0.64

5.28

1.2

1.3

104.80

61.59

au/ml

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

5.21

1.0

0.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

+∞

5.21

1.0

0.0

—

(3033799) Differential panel - Peritoneal fluid

2.94

5.13

2.2

2.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

122

2.47

5.03

1.4

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

122

2.47

5.03

1.4

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

288

1.92

4.95

1.3

1.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1268

11348

1.17

4.95

2.5

3.1

1419.48

1597.08

ng/l

0.96

1120

9792

(3023199) Leukocytes [#/volume] in Pleural fluid

356

1.81

4.80

1.5

842.91

2409.34

e6/l

1.72

264

(4094501) Cardiovascular stress test using bicycle ergometer

963

0.54

4.75

1.0

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

322

1.84

4.71

1.4

1.5

22891.50

71238.14

e6/l

1.07

191

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1404

0.63

4.64

1.2

1.3

—

(3008898) HLA-B27 [Presence]

715

0.48

4.55

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

139

1989

0.69

4.52

2.2

2.4

51.47

23.42

au/ml

—

101

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

305

1.85

4.51

3.2

3.0

—

(3014051) Protein [Presence] in Urine by Test strip

128

864

1.50

4.51

2.9

2.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

423

1.71

4.50

1.9

5.6

238.25

872.98

iu/ml

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

4.18

4.50

1.5

2.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

218

1624

1.36

4.46

1.6

1.5

1.72

1.55

g/l

1.73

187

1392

(3021901) Oxygen saturation in Capillary blood

100

642

1.57

4.43

3.0

2.8

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

189

2.07

4.39

1.3

1.2

9.50

10.63

u/l

0.37

167

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.62

4.39

1.3

2.8

677.40

610.14

e6/l

0.07

(3044007) Cell count panel - Peritoneal fluid

2.89

4.32

1.2

2.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

128

873

1.48

4.30

1.3

1.4

258.59

284.03

ug/g

0.76

533

(3022313) Gas panel - Capillary blood

213

1593

1.36

4.26

3.0

3.7

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

106

697

1.53

4.24

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

106

697

1.53

4.24

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

890

7827

1.17

4.23

4.7

3.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

152

2.18

4.23

1.4

—

(3022806) Fractional oxyhemoglobin in Capillary blood

424

1.69

4.21

1.9

1.8

88.37

89.56

0.72

417

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

234

1.93

4.19

1.4

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

234

1.93

4.19

1.4

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

234

1.93

4.19

1.4

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

153

2.17

4.17

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

999

0.58

4.15

1.2

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

486

0.41

4.14

3.9

4.4

340.44

350.24

umol/l

0.10

413

(3001893) Eosinophils/100 leukocytes in Pleural fluid

2.60

4.13

1.3

1.4

1.39

2.48

0.73

(3005322) IgE [Units/volume] in Serum or Plasma

116

1685

0.68

4.11

1.2

1.3

226.86

238.48

u/ml

0.06

104

1549

(3017354) Segmented neutrophils/100 leukocytes in Blood

265

1.86

4.07

2.4

2.8

55.75

58.91

0.46

214

(3017143) Hepatitis C virus Ab [Presence] in Serum

287

2262

1.29

3.98

1.3

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.67

3.98

1.4

2.5

22825.50

31075.50

e6/l

0.09

(4034850) Laboratory test

1201

0.63

3.88

12.6

10.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1125

0.62

3.84

1.1

1.2

7.40

0.74

u/ml

—

113

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

875

0.58

3.80

1.4

1.6

1.19

3.54

iu/ml

0.34

198

(3002619) Bacteria identified in Specimen by Culture

3.07

3.80

1.3

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

184

1372

1.36

3.79

3.0

3.9

24.85

24.80

mmol/l

0.07

164

1241

(3004119) Hemoglobin [Mass/volume] in Venous blood

289

2299

1.28

3.74

2.5

3.2

123.88

130.61

g/l

5.58

280

2231

(3020682) Albumin/Creatinine [Ratio] in Urine

1109

12230

0.87

3.69

4.0

3.9

10.38

8.44

mg/mmol

0.80

717

7828

(1761868) Lipid panel - Serum or Plasma

877

9827

0.86

3.65

2.9

3.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

102

689

1.49

3.65

1.8

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

389

1.66

3.60

1.3

1.4

—

(3045788) Cell count panel - Pleural fluid

270

1.79

3.56

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1114

0.64

3.53

1.2

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

424

1.61

3.48

1.3

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

424

1.61

3.48

1.3

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.62

3.46

1.3

2.0

11.92

14.62

g/l

0.78

(3024928) Oxygen saturation in Venous blood

107

740

1.46

3.43

1.4

3.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

655

0.55

3.35

1.1

—

(3012516) Albumin [Mass/volume] in Urine

1051

11570

0.88

3.35

3.4

3.2

287.55

231.47

mg/l

0.20

717

7532

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

284

1.73

3.31

1.8

2.1

2.08

1.82

u/field

0.16

101

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

183

1.92

3.28

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

1071

11757

0.88

3.25

3.3

3.2

7.50

7.57

mmol/l

0.20

855

9811

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

609

1.49

3.23

1.3

1.5

—

(3019977) pH of Arterial blood

191

1.89

3.23

1.7

2.1

7.42

7.43

0.34

(3011397) Hemoglobin [Presence] in Urine by Test strip

859

7678

1.15

3.23

3.3

3.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

4.74

3.23

8.2

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

220

1.83

3.22

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1207

0.67

3.19

1.4

1.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

3.54

3.19

1.4

1.1

0.80

2.90

ug/l

—

(3045424) Erythrocytes [Presence] in Urine

514

1.53

3.18

1.8

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

111

790

1.42

3.08

2.6

2.2

122.12

130.70

g/l

2.80

588

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

663

0.57

3.08

1.1

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

235

1874

1.27

3.04

3.1

24.54

25.22

mmol/l

1.74

222

1803

(3021879) Hepatitis B virus core Ab [Presence] in Serum

176

1356

1.31

2.97

1.2

1.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

107

2.16

2.96

1.2

1.4

42.92

64.62

1.43

(3015736) pH of Urine

1346

12445

1.12

2.94

3.6

3.5

5.76

5.79

0.11

596

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

874

0.64

2.91

1.2

1.6

3.01

4.23

mg/l

0.57

645

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

664

0.58

2.91

1.1

1.3

4.29

25.38

e6/l

1.32

521

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

664

0.58

2.91

1.2

1.4

235.67

867.16

e6/l

1.53

550

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

5.39

2.86

1.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2796

28932

0.89

2.85

3.8

4.5

2.03

2.07

mu/l

0.27

2459

25995

(3024891) Influenza virus A+B Ag [Presence] in Specimen

676

1.43

2.85

1.1

1.2

—

(40765096) Chromosome analysis panel by Banding

3.16

2.84

1.2

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.23

2.79

3.8

2.8

—

(3035880) pH of Pleural fluid

158

1.90

2.79

1.2

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

274

3316

0.81

2.78

1.2

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

271

0.37

2.76

1.0

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

277

1.67

2.76

3.3

—

(3017732) Neutrophils [#/volume] in Blood

246

2001

1.24

2.71

4.7

3.2

4.22

5.66

e9/l

2.64

199

1480

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

325

1.61

2.71

1.2

1.1

—

(3011648) Oxygen content in Venous blood

264

1.67

2.69

1.2

2.0

11.53

11.11

0.26

264

(3028707) Methadone [Presence] in Urine by Screen method

167

0.30

2.68

1.0

2.0

—

(21494755) Public health laboratory ask at order entry panel

124

1646

0.75

2.68

1.2

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

4.22

2.67

1.1

1.0

—

(36660697) Celiac disease serology panel - Serum

260

2136

1.23

2.63

1.1

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1025

0.69

2.56

1.2

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

387

1.53

2.53

1.2

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

676

1.40

2.52

1.0

1.1

1.21

8.92

u/ml

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

444

1.49

2.52

1.2

1.3

—

(3011544) Albumin [Mass/volume] in Pleural fluid

3.81

2.46

1.0

1.1

22.22

15.70

g/l

—

(3032773) Endomysium IgG Ab [Titer] in Serum

210

1.72

2.46

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

259

3109

0.82

2.45

1.5

—

(3017569) Oxygen content in Arterial blood

198

1.72

2.35

2.1

1.7

—

(3000494) Fungus identified in Specimen by Culture

412

3584

1.17

2.26

1.5

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

775

0.67

2.25

1.2

—

46.94

—

(3019832) Treponema pallidum Ab [Presence] in Serum

928

0.70

2.25

1.2

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

278

1.59

2.25

1.0

1.1

3.22

2.26

u/ml

0.30

(3000475) Leukocytes [#/volume] in Synovial fluid

914

0.70

2.22

1.5

8688.51

14364.50

e6/l

0.91

665

(3044242) Glucose [Moles/volume] in Arterial blood

196

1.69

2.15

2.1

1.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

730

0.67

2.14

1.2

1.76

5.01

u/ml

—

122

(3006442) Creatine [Moles/volume] in Serum or Plasma

221

1.63

2.08

1.4

1.7

91.86

92.42

umol/l

0.03

221

(44816559) Phosphatidylethanol [Mass/volume] in Blood

507

0.61

2.07

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

261

1.58

2.05

1.9

1.4

—

(3024263) Appearance of Synovial fluid

202

0.44

1.95

1.0

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.45

1.92

1.0

1.2

82.64

152.72

ng/l

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

327

2835

1.17

1.91

1.3

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

604

0.66

1.90

1.1

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

280

0.50

1.89

1.0

2.64

4.03

u/ml

—

127

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

406

1.43

1.89

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

152

1869

0.81

1.88

1.8

1.9

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

181

1.66

1.88

2.3

2.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

419

4716

0.88

1.84

11.8

7.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

400

1.43

1.84

8.7

24.9

6.74

7.59

mmol/l

2.01

329

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

328

0.55

1.82

1.0

1.1

1.42

1.36

u/ml

—

160

(3008401) Mugwort IgE Ab [Units/volume] in Serum

276

0.51

1.82

1.0

1.1

1.79

0.82

u/ml

—

108

(3042111) Morphology [Interpretation] in Bone marrow Narrative

403

1.42

1.78

1.8

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.34

1.77

2.2

1.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

233

0.47

1.77

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

150

0.40

1.76

1.0

—

15.66

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

497

1.37

1.75

1.2

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

270

0.52

1.72

1.0

1.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

589

0.68

1.71

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

307

1.47

1.70

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

332

0.57

1.69

1.0

1.9

—

(3021960) Folate [Moles/volume] in Serum or Plasma

904

8404

1.10

1.68

1.6

19.95

20.19

nmol/l

0.18

778

7087

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

943

0.75

1.65

1.4

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

355

0.59

1.65

1.4

1.3

9183.00

245848.61

e6/l

4.49

243

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.03

1.64

1.1

1.2

—

(3042631) Mycobacterium sp identified in Specimen

427

1.39

1.63

1.8

3.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

388

3449

1.14

1.63

2.4

3.1

234.47

229.45

ng/l

0.08

347

3172

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

378

0.61

1.63

1.3

1.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

132

0.38

1.61

3.2

2.9

30.40

29.34

umol/l

—

(3027008) Opiates [Presence] in Urine

352

0.59

1.61

1.0

1.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.87

1.60

1.4

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

287

1.47

1.59

1.8

1.4

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.69

1.58

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

208

0.48

1.56

1.0

1.1

6.39

2.50

u/ml

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

247

0.52

1.55

1.2

1.4

189.42

204.43

pmol/l

0.14

247

(3019150) Specific gravity of Urine by Refractometry

666

7218

0.91

1.53

4.2

1.02

kg/l

0.46

104

1058

(3045683) HLA typing for celiac disease panel - Blood or Tissue

115

1.74

1.52

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1631

15608

1.07

1.47

4.6

3.9

2.66

2.03

ug/l

2.34

1405

13983

(3025130) Human papilloma virus identified in Specimen

155

1.62

1.46

1.5

1.9

—

(3014891) Appearance of Pleural fluid

2.22

1.46

1.8

1.2

—

(3028300) Cannabinoids [Presence] in Urine

354

0.62

1.45

1.0

1.8

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

317

0.60

1.45

1.1

—

1.40

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

171

1.58

1.45

1.4

12.33

8.69

u/l

0.40

143

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

122

1487

0.81

1.45

1.2

181.67

125.03

iu/ml

0.69

549

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.73

1.43

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.73

1.43

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.73

1.43

1.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

339

0.62

1.41

1.4

1.5

41.00

27.85

0.61

221

(3011288) Drugs identified in Urine by Screen method

226

0.53

1.41

1.0

2.6

—

(3000764) Benzodiazepines [Presence] in Urine

351

0.62

1.41

1.0

1.8

—

(3022621) pH of Urine by Test strip

250

2181

1.16

1.41

3.3

3.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

205

1.52

1.40

2.0

2.1

64.75

219.80

ug/min

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

165

1.58

1.39

2.9

1.4

198.57

2161.39

u/l

0.66

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.85

1.39

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

2.08

1.38

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

2.08

1.38

1.3

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.00

1.37

1.0

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

150

1.60

1.37

1.0

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

299

0.60

1.37

1.1

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

102

1257

0.81

1.36

1.8

1.7

38.62

37.93

u/l

0.11

1054

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

766

0.75

1.35

1.9

1.8

11.32

11.88

mg/l

0.20

701

(3014271) Vancomycin [Susceptibility]

215

1.49

1.35

3.0

2.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1023

0.79

1.34

2.6

2.1

183.61

114.84

ug/min

0.41

595

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

209

0.52

1.34

2.0

1.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1257

11955

1.07

1.33

4.7

4.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

2.04

1.32

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

2.04

1.32

1.3

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

796

0.76

1.31

1.7

—

(3027944) Amphetamines [Presence] in Urine

344

0.64

1.31

1.0

1.7

—

(3020876) Protein [Mass/time] in 24 hour Urine

377

1.36

1.30

2.7

2.2

0.73

1.47

g/24h

2.55

181

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.76

1.28

1.1

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

132

0.45

1.28

1.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

713

0.75

1.27

1.4

1.6

—

(3005033) Fetal Nuchal fold Thickness US

2.09

1.27

1.3

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

192

0.52

1.27

1.5

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

304

0.62

1.26

1.2

1.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

458

0.70

1.25

1.4

1.5

57.00

61.31

0.20

303

(4146454) Self-monitoring of blood glucose

432

1.32

1.24

3.2

2.8

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

160

0.50

1.24

1.1

1.0

—

(3021788) Differential panel - Synovial fluid

664

0.75

1.23

1.3

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

2.04

1.21

1.3

1.4

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

301

0.63

1.21

1.1

—

25.86

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

953

0.79

1.21

3.1

1.5

0.00

g/l

-0.00

873

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.63

1.21

1.0

2.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

213

1.46

1.20

2.5

2.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

164

1.53

1.20

2.2

1.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

101

1.69

1.19

1.5

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

101

1.69

1.19

1.5

2.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

197

1.48

1.19

1.1

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1049

0.81

1.19

3.2

1.5

0.01

0.03

g/l

1.06

954

(3001019) Free T4 and TSH panel - Serum or Plasma

861

0.79

1.18

1.5

1.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

235

0.59

1.14

1.0

1.1

2.88

1.19

u/ml

—

115

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

142

1.55

1.14

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

142

1.55

1.14

1.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

711

6658

1.08

1.13

1.6

1.7

2.16

1.28

mg/l

3.79

582

5153

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.85

1.13

1.3

1.1

—

(3023419) Bacteria identified in Sputum by Culture

563

0.74

1.13

2.3

2.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.96

1.11

1.4

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

110

1311

0.83

1.10

2.6

1.4

10.45

10.31

g/l

0.13

1135

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

404

4407

0.91

1.10

4.3

5.0

32.66

32.85

0.14

264

2951

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

137

0.51

1.09

1.0

1.1

—

1.09

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

160

1.50

1.09

1.3

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

971

0.81

1.08

3.0

1.5

0.00

g/l

-0.00

877

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

119

1402

0.84

1.06

2.7

1.4

3.58

3.76

g/l

0.85

1233

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.06

1.02

3.1

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.84

1.02

1.4

1.5

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.74

1.02

1.3

1.4

17.86

29.18

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

120

1407

0.85

1.02

2.7

1.4

7.35

7.46

g/l

0.30

1237

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

120

1407

0.85

1.02

2.7

1.4

—

(3023410) Appearance of Cerebral spinal fluid

275

0.65

1.01

1.1

1.5

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.17

0.98

1.0

1.1

—

5.38

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

135

0.52

0.98

1.0

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

627

0.78

0.97

1.1

1.2

—

7.87

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.00

0.97

0.0

1.1

—

78.18

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.97

0.0

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

235

0.64

0.96

1.1

1.2

2.74

2.12

mmol/l

0.81

221

(3001729) Color of Synovial fluid

0.00

0.95

0.0

1.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.95

0.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

258

0.66

0.94

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

119

0.50

0.93

1.2

41.83

57.96

—

104

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.22

0.93

10.3

11.1

—

(3000492) Spirometry study

250

2766

0.90

0.92

1.4

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

146

0.55

0.92

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1113

0.84

0.92

2.7

1.4

37.20

37.73

g/l

0.34

943

(3023420) DNA double strand Ab [Units/volume] in Serum

279

0.68

0.90

1.2

1.3

—

24.07

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

160

1.44

0.88

1.3

1.2

—

(3003181) Sodium [Moles/volume] in Urine

595

1.21

0.85

1.5

1.4

71.00

62.66

mmol/l

0.70

479

(3052592) Norovirus Ag [Presence] in Stool

1.67

0.85

1.6

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

167

0.60

0.85

2.2

—

(3036603) Volume of Urine

179

1.40

0.83

1.8

1.3

1823.48

1859.87

0.09

169

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

434

1.25

0.83

1.7

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

113

0.53

0.83

1.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

283

3087

0.91

0.82

1.5

1.7

1.59

1.57

0.16

243

2613

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

398

0.75

0.81

1.1

1.2

265.14

196.89

miu/ml

—

146

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

101

1173

0.86

0.81

2.9

1.5

0.66

0.42

g/l

0.58

1002

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

103

1193

0.86

0.80

1.6

193.33

284.59

titre

—

(3044941) Cell count panel - Synovial fluid

586

0.80

0.79

1.3

1.4

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.79

0.0

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.79

0.0

1.4

—

(3019174) dRVVT (LA screen)

0.00

0.79

0.0

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.78

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

585

0.80

0.78

1.7

6.37

4.71

iu/l

0.23

179

(3020650) Glucose [Presence] in Urine

1.67

0.78

1.5

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

0.78

0.0

1.1

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

0.00

0.78

0.0

1.5

—

0.72

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.00

0.78

0.0

1.0

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

0.77

0.0

1.3

—

0.83

—

(4062490) Immunoglobulin typing, IgG

292

0.72

0.77

1.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

115

1.48

0.76

1.8

2.2

93.65

94.95

0.05

106

(3000330) Specific gravity of Urine by Test strip

203

1836

1.11

0.75

5.7

3.3

—

(4212803) Bone marrow aspirate examination

2.08

0.74

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.00

0.72

1.6

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

171

0.64

0.72

1.1

—

(3004775) Volume in Urine collected for unspecified duration

333

0.75

0.71

1.8

2.3

653.40

625.58

0.19

220

(21494434) Karyotype in Bone marrow

246

1.30

0.71

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.55

0.71

2.5

2.2

8.30

8.14

mmol/l

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

298

0.74

0.70

1.0

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

823

1.16

0.70

2.5

1.5

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

1.55

0.69

1.3

1.9

29.89

26.21

—

(3006245) CD3-CD19+ cells/100 cells in Blood

1.55

0.69

1.3

1.9

17.56

8.22

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

145

0.62

0.69

1.7

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

420

0.78

0.69

1.0

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

845

0.85

0.69

1.4

1.5

0.26

0.23

g/l

1.28

802

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.85

0.68

1.0

1.1

8.20

9.74

u/l

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

204

0.68

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

204

0.68

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

204

0.68

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

117

1322

0.88

0.67

2.7

1.4

2.96

2.94

g/l

0.12

1153

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.54

0.66

1.2

1.4

10.62

9.40

ug/l

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1525

14845

1.04

0.66

2.1

86.66

93.32

pmol/l

6.84

906

7760

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

190

0.68

0.65

1.4

1.9

16.84

15.29

nmol/l

0.27

168

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.59

0.65

2.4

2.6

0.57

0.36

u/field

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.59

0.65

1.7

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

643

1.17

0.64

1.3

1.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

201

0.70

0.64

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

201

0.70

0.64

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

201

0.70

0.64

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

223

0.72

0.62

1.0

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

291

0.75

0.62

1.4

0.29

0.41

g/l

1.47

213

(3027135) IgG subclass 1 [Mass/volume] in Serum

291

0.75

0.62

1.4

6.04

6.93

g/l

0.62

213

(3028192) IgG subclass 2 [Mass/volume] in Serum

291

0.75

0.62

1.4

2.30

2.97

g/l

1.79

211

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

479

0.81

0.62

1.4

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

323

0.77

0.60

1.0

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.48

0.60

1.3

1.5

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.60

0.0

1.9

—

1.25

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

389

1.21

0.60

1.2

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

345

0.78

0.60

1.0

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.60

0.0

1.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.60

0.0

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

163

0.67

0.60

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

272

1.25

0.59

1.0

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

427

1.20

0.58

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

229

2474

0.92

0.58

2.5

1.5

—

(3022689) Creatine [Moles/volume] in Urine

114

0.61

0.58

1.3

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

273

1.25

0.57

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.71

0.57

1.0

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

331

0.78

0.57

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.67

0.56

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.58

0.56

1.0

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

0.57

0.56

1.0

1.1

—

30.00

—

(3004616) Nuclear Ab [Presence] in Serum

385

0.80

0.56

1.1

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.62

0.55

1.3

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

1.54

0.55

1.0

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

123

1107

1.11

0.55

2.7

1.5

34.55

35.66

mg/l

0.12

102

896

(44813793) Dust mix specific IgE antibody measurement

171

0.70

0.54

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

195

1.28

0.54

1.1

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

123

1109

1.11

0.53

2.7

1.5

54.53

48.49

mg/l

0.44

103

902

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

348

3685

0.94

0.53

2.0

2.4

6.22

7.61

ug/l

0.74

297

3225

(3050129) First trimester maternal screen panel - Serum or Plasma

1.45

0.53

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

117

1.37

0.52

1.2

2.1

17.19

16.89

0.04

111

(3047189) Immunofixation for 24 hour Urine

126

1.35

0.51

1.6

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

118

1.36

0.50

1.4

1.6

97.25

149.16

umol/l

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

701

0.87

0.49

1.3

1.5

1.16

0.79

nmol/l

1.30

572

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

136

1.32

0.49

1.1

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

428

1.17

0.48

1.2

1.3

44.86

31.18

iu/l

1.80

373

(3004451) EKG impression Narrative

190

1.26

0.47

1.2

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.49

0.47

1.3

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

102

1.37

0.47

1.7

2.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

484

0.85

0.47

1.1

176.70

415.17

iu/ml

—

100

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

541

1.15

0.47

3.1

3.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.46

0.46

1.4

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

111

1.35

0.46

1.2

2.1

—

(3006270) Folate [Moles/volume] in Blood

320

0.81

0.45

1.3

1.2

363.87

346.13

nmol/l

0.16

258

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.59

0.45

1.0

1.5

191.80

74.58

nmol/24h

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

599

0.87

0.45

1.1

1.2

108.58

24.06

u/l

0.72

517

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

238

2533

0.94

0.45

3.1

3.9

94.05

97.55

ng/l

0.21

197

2142

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

431

1.16

0.45

1.6

2.2

52.42

25.99

mg/l

0.74

(3024980) IgG subclass 4 [Mass/volume] in Serum

449

0.84

0.44

1.3

1.7

1.18

0.92

g/l

0.32

347

(3044927) Protein electrophoresis panel - Urine

416

0.84

0.44

1.1

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

121

1.32

0.44

1.2

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

208

0.77

0.43

1.3

1.2

0.20

1.19

u/ml

1.22

117

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

318

0.82

0.43

2.0

1.7

32.17

25.08

u/ml

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

490

0.86

0.43

1.4

1.3

21.36

8.72

u/l

2.97

394

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

118

1078

1.10

0.43

2.7

1.5

1.39

2.61

ratio

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

104

1.35

0.43

1.1

1.5

—

(3034426) Prothrombin time (PT)

0.64

0.42

1.2

—

(1175426) CD3 cells/100 lymphocytes in Blood

122

1.31

0.42

1.2

2.1

66.69

73.25

1.25

111

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.41

0.0

1.1

—

(3003577) Lead [Moles/volume] in Blood

0.00

0.41

0.0

1.3

—

0.14

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.41

0.0

1.5

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.08

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.17

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.40

0.0

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

120

1102

1.09

0.40

2.0

2.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

106

968

1.10

0.40

4.8

4.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

1.36

0.40

7.2

1.1

23.12

50.98

u/ml

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

1.34

0.39

2.8

2.2

37.33

44.53

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.39

0.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

106

0.66

0.39

1.1

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

106

0.66

0.39

1.1

1.2

—

0.06

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

133

1.28

0.38

2.6

2.7

49952.94

40223.63

ug/l

1.52

133

(3006462) Nitrate [Presence] in Urine

151

1.26

0.38

4.2

3.4

—

(3048879) Bone marrow aspiration report

1.38

0.38

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.38

0.38

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

382

1.15

0.38

1.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

252

1.19

0.37

1.3

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.35

0.37

2.4

2.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.35

0.37

2.4

2.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

114

0.70

0.37

1.5

2.0

81.08

49.70

ug/l

—

109

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

152

1.25

0.36

1.2

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

134

1442

0.93

0.36

3.1

2.9

4.35

4.40

pmol/l

0.26

126

1238

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

135

0.74

0.36

2.0

2.2

53.60

56.52

umol/l

—

111

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.63

0.35

1.0

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1235

12587

0.97

0.35

4.0

3.8

20.37

24.40

16.97

588

6173

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

416

0.86

0.35

1.1

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

867

0.91

0.34

1.4

1.5

1.14

1.17

g/l

0.32

819

(3003338) MCHC [Mass/volume]

2610

25848

1.03

0.34

40.1

18.3

329.80

332.53

g/l

41.12

2590

25598

(3005719) IgG [Mass/volume] in Serum or Plasma

206

1949

1.06

0.33

2.5

2.2

9.72

10.82

g/l

3.34

190

1781

(3002079) Sodium [Moles/time] in 24 hour Urine

133

0.75

0.33

1.3

1.2

166.80

172.81

mmol/24h

—

133

(3025577) Chromium [Mass/volume] in Blood

275

0.84

0.33

2.0

2.66

1.79

ug/l

0.62

227

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

127

1.26

0.33

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.69

0.33

1.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

251

2630

0.95

0.32

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

211

1.19

0.31

1.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

437

1.12

0.31

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

100

0.70

0.30

1.0

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

207

0.82

0.30

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

206

0.82

0.29

1.2

1.5

15.44

14.12

umol/l

0.24

189

(3019309) Folate [Moles/volume] in Red Blood Cells

718

7349

0.97

0.28

1.7

1.8

1175.72

1151.39

nmol/l

0.26

541

5514

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

393

1.12

0.28

1.3

1.2

3.00

5.55

u/ml

1.49

176

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

384

1.12

0.27

1.2

1.5

78.47

112.29

u/ml

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

118

0.76

0.27

1.1

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1290

12700

1.02

0.27

2.1

2.2

76.25

78.55

nmol/l

1.92

1129

11060

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

309

1.13

0.26

1.3

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

309

1.13

0.26

1.3

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.68

0.26

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

0.67

0.25

1.2

163.80

254.27

pmol/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1581

15610

1.02

0.25

2.2

2.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

733

1.08

0.25

2.5

2.7

1.87

1.73

mg/l

0.65

646

(3034274) Bile acid [Moles/volume] in Serum --fasting

114

1.23

0.25

2.1

1.2

16.01

8.10

umol/l

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

403

0.89

0.25

1.2

1.3

234.89

302.30

pmol/l

0.97

341

(3016650) Hepatitis A virus Ab [Presence] in Serum

359

1.12

0.24

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.28

0.24

1.1

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.74

0.24

4.0

7.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.73

0.24

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.71

0.24

1.0

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

208

1.15

0.23

6.1

10.5

—

(40768443) Skin Pathology biopsy report

119

1258

0.94

0.23

1.1

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

399

1.10

0.23

1.3

1.2

5.13

3.37

u/ml

0.26

115

(3051387) C reactive protein [Mass/volume] in Capillary blood

753

0.93

0.23

3.7

3.6

34.92

27.70

mg/l

0.64

489

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

125

1.20

0.22

1.9

1.7

516.00

682.34

e6/l

1.05

119

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.27

0.22

1.2

1.4

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.21

0.0

1.4

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.11

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.9

—

1.81

—

(3042517) Benzodiazepines panel - Urine

0.00

0.21

0.0

1.2

—

(40768797) Stomach Pathology biopsy report

443

4321

1.03

0.21

1.3

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

105

0.76

0.21

2.9

3.2

14.45

20.37

mu/l

—

(3010503) CD19 cells [#/volume] in Blood

105

0.76

0.21

1.0

1.9

0.12

0.13

e9/l

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.21

0.0

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

387

0.90

0.20

1.2

200.56

281.83

u/ml

1.69

243

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.09

—

(3011985) Renin [Units/volume] in Plasma

428

0.91

0.20

1.3

38.77

61.00

mu/l

1.04

379

(21494890) Protein electrophoresis panel - 24 hour Urine

326

1.10

0.20

2.5

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

199

2064

0.96

0.20

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

115

0.78

0.20

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

254

2459

1.03

0.19

1.8

410.08

367.67

nmol/l

2.67

236

2206

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.20

0.19

1.0

2.4

—

(3035933) Granulocytes/100 leukocytes in Blood

1.20

0.19

1.3

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.17

0.17

1.0

2.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.15

0.17

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

142

0.84

0.17

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

279

2865

0.97

0.17

2.6

1.6

64.67

66.75

g/l

3.87

247

2536

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

152

0.85

0.17

1.0

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

148

1.15

0.16

1.1

1.3

5.95

6.21

mmol/l

0.47

137

(3037756) Immunofixation for Serum or Plasma

660

1.06

0.16

1.6

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.16

0.16

1.1

1.2

17.61

15.70

umol/l

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

788

7770

1.02

0.16

1.7

29032715.79

29799436.95

pmol/l

0.01

651

6319

(40761535) Cells panel - Urine sediment

294

3011

0.97

0.15

3.0

3.4

—

(3038026) Centromere Ab [Units/volume] in Serum

265

0.90

0.15

1.1

1.2

—

67.95

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.81

0.14

1.0

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.81

0.14

1.7

0.90

1.04

ug/l

—

(3016750) Collection duration of Urine

223

0.90

0.14

1.8

2.0

493.08

496.52

min

0.04

168

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

100

1040

0.96

0.13

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

157

0.89

0.11

1.0

1.2

154.57

141.69

nmol/l

0.23

157

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.11

0.09

1.0

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

164

1.10

0.09

1.1

1.4

1.55

1.54

g/l

0.05

164

(3008295) Osmolality of Serum or Plasma

301

1.06

0.09

1.3

1.4

275.19

278.49

mosm/kgh2o

0.42

226

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.05

0.08

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

369

0.95

0.08

1.2

1.3

—

nmol/l

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.79

0.08

1.0

—

(3016228) CD19 cells/100 cells in Blood

1.08

0.08

1.0

2.3

10.14

7.45

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.06

0.08

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.80

0.07

1.3

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

1.03

0.07

2.4

1.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

153

0.91

0.07

1.0

1.5

—

(40757373) Influenza virus identified in Isolate

0.84

0.07

1.1

1.5

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.07

0.07

1.0

2.2

—

144634.92

—

(3028026) IgM [Mass/volume] in Serum or Plasma

152

1547

0.98

0.06

1.9

1.4

1.36

1.14

g/l

0.56

140

1400

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

101

0.89

0.06

1.1

—

(3015183) Erythrocyte sedimentation rate

103

0.87

0.06

1.3

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

121

0.91

0.06

1.0

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

867

8711

0.99

0.05

3.0

2.8

0.75

0.71

ug/l

0.28

600

6033

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

373

0.96

0.04

1.2

1.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

328

1.04

0.04

1.1

—

u/ml

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

331

0.97

0.03

3.2

3.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

389

0.98

0.02

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

177

0.96

0.01

3.1

4.9

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

851

1.01

0.01

3.0

3.1

0.76

0.82

nmol/l

0.94

659

(3017446) Testosterone [Moles/volume] in Serum or Plasma

217

2159

1.01

0.01

1.9

2.2

10.95

14.71

nmol/l

7.49

183

1895

(3048929) Epstein Barr virus Ab [Presence] in Serum

542

1.01

0.01

1.1

1.2

—

(40768446) Kidney Pathology biopsy report

122

0.98

0.00

1.3

1.6

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

243

0.99

0.00

1.1

1.2

—

4.17

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

526

1.01

0.00

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

446

1.01

0.00

1.2

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

189

1.01

0.00

1.4

1.3

1.09

1.22

nmol/l

0.22

143

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

147

1.02

0.00

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

263

0.99

0.00

2.5

2.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

367

1.01

0.00

1.0

1.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

111

0.99

0.00

5.2

7.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

516

1.01

0.00

1.5

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

154

0.97

0.00

1.2

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

648

1.00

0.00

1.1

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

375

1.01

0.00

3.3

3.0

46.08

38.46

mg/l

0.21

284

(3017704) Immunofixation for Urine

199

1.00

0.00

1.3

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

475

0.99

0.00

3.2

2.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.3

—

3.78

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.3

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.0

1.7

—

9.17

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.98

0.00

1.0

1.1

128.33

101.96

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

5.4

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.95

-0.00

4.9

1.7

221.33

160.61

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.94

-0.00

4.8

7.7

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

-0.00

0.0

2.2

—

921.83

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

157.43

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

0.97

-0.00

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

4.8

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1352.00

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

-0.00

0.0

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

2.06

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

2273.60

—

(3028433) Virus identified in Specimen by Culture

1.00

-0.00

1.3

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3003129) Base excess in Capillary blood by calculation

0.93

-0.00

1.0

1.5

-0.52

0.37

mmol/l

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

6.4

—

0.21

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

-0.00

0.0

3.8

—

20.67

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3008607) Semen analysis panel

0.00

-0.00

0.0

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

250.89

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.87

-0.00

1.2

1.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

1.33

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

1.92

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.97

-0.00

1.5

105.17

137.53

ng/l

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

121.40

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_RECTUM_ADENO_MUCINO – Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

GWS hits: 12

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum (C3_RECTUM_ADENO_MUCINO)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints